Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin B1 interacting protein 1 pseudogene 2 (CCNB1IP1P2) is a human pseudogene—a genomic DNA sequence similar to the gene encoding cyclin B1 interacting protein 1 but classified as a non-functional copy and not translated into a protein[1][5]. Pseudogenes, by definition, lack protein-coding potential and do not serve as receptors, enzymes, or other canonical drug targets[2][4]. There is no evidence of this locus functioning in signaling pathways, disease, or as a therapeutic target. No alternate names or known interacting compounds have been described. While some pseudogenes may exert regulatory roles, no such function has been defined or proposed for CCNB1IP1P2 specifically.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin B1 interacting protein 1 pseudogene 2 (CCNB1IP1P2).